Company: XAIR
Filing Date: 2025-06-20
Form Type: 10-K
Source: 0001641172-25-015750
Chunk: 1338

Company: Beyond Air, Inc.
Filing Date: 2025-06-20
Form: 10-K
Item: Item 3
Chunk 1338
---
 Circassia, ($2.9) million for the Hudson settlement and ($7.6) million attributable
to the resolution of the Empery Suit.

Investing Activities

For the year ended March 31, 2025,
cash provided by investing activities was $14.9 million which was primarily from investments in marketable securities from net proceeds received
from the purchase and sale of marketable securities of $20.8 million in the fiscal year, and the purchase of property and equipment for
$5.9 million. For the year ended March 31, 2024, cash used in investing activities was $12.2 million which was primarily from investments
in marketable securities from net proceeds received from the purchase and sale of marketable securities of $6.5 million in the fiscal
year, and the purchase of property and equipment for $5.7 million.

81

Financing Activities

For the year ended March 31, 2025,
net cash provided by financing activities was $16.6 million, mainly from the issuance of securities through securities purchase agreements
which the net proceeds were $18.8 million, $11.3 million payment received on the loan agreement, and the issuance of common stock in connection
with an At-The-Market Offering Sales Agreement with Truist Securities, Inc. (the “2022 ATM”) of $0.7 million and $1.5 million
in connection with the 2025 ATM partially offset by $18.0 million from the payment of long- and short-term loans, including a $17.5 million
repayment to Avenue Capital. For the year ended March 31, 2024, net cash provided by financing activities was $43.2 million, mainly from
the Loan Agreement of which the net proceeds were $15.8 million, the issuance of common stock in connection with the 2022 ATM of $13.4
million, and the registered direct offering (the “Registered Offering”) pursuant to a securities purchase agreement dated
March 20, 2024 with Roth Capital Partners, LLC and Laidlaw & Company (UK) Ltd. of $14.6 million, the issuance of common
stock in connection with the exercise of options ($0.2 million) partially offset by $0.8 million from the payment of short-term loans.

ITEM 7A. Quantitative and Qualitative Disclosure
about Market Risk

We qualify as a smaller reporting
company, as defined by SEC Rule